Interpretation and prospect to the "Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products Guidance for Industry(2019)"

DU Pei-yan; LIU Qiong; WEI Peng-lu; WANG Nian; YU Ya-nan; CHEN Qi-guang; LIU Jun; WANG Zhong

doi:10.3969/j.issn.1003-3734.2020.08.011

Home>Articles>Interpretation and prospect to the "Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products Guidance for Industry(2019)"

DOI: 10.3969/j.issn.1003-3734.2020.08.011

Interpretation and prospect to the "Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products Guidance for Industry(2019)"

DU Pei-yan

LIU Qiong

WEI Peng-lu

WANG Nian

YU Ya-nan

CHEN Qi-guang

LIU Jun

WANG Zhong

Machine-generated Keywords：

Publication Date：2020-04-30

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 908-913 )

Chinese Journal of New Drugs

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2020,29(8)